Cancer Immunotherapy Translational Science Network | Pediatric Immunotherapy-Discovery and Development Network (PI-DDN) (U54) | RFA-CA-19-003 | 12/17/2018 |
Cancer Immunotherapy Translational Science Network | Pediatric Immunotherapy- Discovery and Development Network (PI-DDN) (U01) | RFA-CA-19-004 | 12/17/2018 |
Cancer Immunotherapy Translational Science Network | Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) | PAR-17-245 | Multiple |
Cancer Immunotherapy Translational Science Network | Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) | PAR-17-244 | Multiple |
Cancer Immunotherapy Translational Science Network | Metabolic Reprogramming to Improve Immunotherapy (R21) | PAR-16-229 | Multiple |
Cancer Immunotherapy Translational Science Network | Metabolic Reprogramming to Improve Immunotherapy (R01) | PAR-16-228 | Multiple |
Prevention and Early Detection: Implementation Science | Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01) | RFA-CA-19-017 | 1/9/2019 |
Prevention and Early Detection: Implementation Science | Communication and Decision Making for Individuals with Inherited Cancer Syndromes (U01) | RFA-CA-19-001 | 1/9/2019 |
Drivers of Childhood Cancers | Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54) | RFA-CA-19-016 | 12/7/2018 |
Drivers of Childhood Cancers | Gene Fusions in Pediatric Sarcomas (R21) | PA-16-252 | Multiple |
Drivers of Childhood Cancers | Gene Fusions in Pediatric Sarcomas (R01) | PA-16-251 | Multiple |
Generation of Human Tumor Atlases | Emerging Questions in Cancer Systems Biology (U01) | PAR-16-131 | Multiple |
Cancer Immunotherapy Translational Science Network
| Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (UG3/UH3 Clinical Trials Not Allowed)
| RFA-CA-19-012 | 2/11/2019 |
Cancer Immunotherapy Translational Science Network
| Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers (U54 Clinical Trial Not Allowed)
| RFA-CA-19-013 | 2/11/2019 |
Cancer Immunotherapy Translational Science Network
| Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01 Clinical Trial Not Allowed)
| RFA-CA-19-014 | 2/8/2019 |
Cancer Immunotherapy Translational Science Network
| Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01 Clinical Trial Not Allowed)
| RFA-CA-19-015 | 2/8/2019 |
Prevention and Early Detection: Implementation Science
| Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS, Second Wave) (UG3/UH3 Clinical Trial Required)
| RFA-CA-19-018 | 2/11/2019 |
No hay comentarios:
Publicar un comentario